Orthodenticle homeobox 2 (OTX2)

Orthodenticle homeobox 2 (OTX2) is a homeodomain-containing transcription factor critical for embryonic development and maintenance of sensory organs, particularly the brain, eye, and retina. OTX2 regulates the expression of genes responsible for neurodevelopment, photoreceptor differentiation, and maturation of neural circuits critical for vision and plasticity. Mutations or dysregulation of OTX2 are associated with a spectrum of developmental disorders, including anophthalmia, microphthalmia, combined pituitary hormone deficiency, intellectual disabilities, and certain cancers such as medulloblastoma. OTX2 is transported between cells (notably from the choroid plexus to visual cortex neurons), participates in experience-dependent neural plasticity, and serves as a biomarker in specific cancer types and developmental disorders. While not presently a direct pharmacological target, OTX2 is of major interest in developmental biology and disease research due to its central regulatory role and disease associations[1][2][3][4][6][7].

Other names

Homeobox protein OTX2Orthodenticle homolog 2CPHD6MCOPS5orthodenticle homolog 2

Not directly drug-targeted; as a transcription factor, therapeutic targeting would likely involve gene expression modulation or protein-protein interaction inhibition rather than receptor/ligand pharmacology[3][6].